OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16

Molecular and Cellular Biochemistry

Volumn 354, Issue 1-2, 2011, Pages 199-205

  Kong, Fandou ^a   Tong, Rui ^a   Jia, Lingyu ^a   Wei, Wei ^a   Miao, Xiaoyan ^a   Zhao, Xinyu ^a   Sun, Wenping ^a   Yang, Guang ^a   Zhao, Chunyan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Cell proliferation; Cyclin D1; NF B; Ovarian cancer; OVCA1; P16

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P16; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; OVCA1 GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B; OVARIAN NEOPLASMS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 79959795435     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0819-0     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225-249. doi:10.3322/caac.20006
2. Cho KR, Shih I-M (2009) Ovarian cancer. Annu Rev Pathol: Mech Dis 4(1):287-313. doi:10.1146/annurev.pathol.4.110807.092246
3. Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, Massie CE, Miller J, Contreras-Moreira B, Scott D, Brown I, Williams AR, Bates PA, Smyth JF, Gabra H (2003) OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet 34 (3):337-343. doi:http://www.nature.com/ng/journal/v34/n3/suppinfo/ng1183-S1.html
4. Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao D-F, Wang T-L, Kurman RJ, Shih I-M (2005) Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol 29(2):218-224 (Pubitemid 40170640)
5. Singer G, Oldt R III, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih I-M (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95(6):484-486. doi:10.1093/jnci/95. 6.484 (Pubitemid 36432423)
6. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ, Godwin AK (1996) Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 56 (9):1997-2002 (Pubitemid 26119896)
7. Schultz DC, Balasara BR, Testa JR, Godwin AK (1998) Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2. Genomics 52(2):186-191. doi:10.1006/geno.1998.5420 (Pubitemid 28465665)
8. Phillips NJ, Ziegler MR, Radford DM, Fair KL, Steinbrueck T, Xynos FP, Donis-Keller H (1996) Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res 56 (3):606-611 (Pubitemid 26043661)
9. Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, Godwin AK (1999) Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Res 59(19):4973-4983 (Pubitemid 29472903)
10. Wiper DW, Zanotti KM, Kennedy AW, Belinson JL, Casey G (1998) Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers. Gynecol Oncol 71(1):77-82. doi:10.1006/gyno.1998.5110 (Pubitemid 28492397)
11. Phillips NJ, Zeigler MR, Deaven LL (1996) A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3. Cancer Lett 102 (1-2):85-90 (Pubitemid 26097807)
12. Chen CM, Behringer RR (2004) Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev 18(3):320-332. doi:10.1101/gad.1162204
13. Atanasoski S, Boller D, De Ventura L, Koegel H, Boentert M, Young P, Werner S, Suter U (2006) Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 53(2):147-157. doi:10.1002/glia.20263
14. Tashiro E, Tsuchiya A, Imoto M (2007) Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 98(5):629-635 (Pubitemid 46563437)
15. Wolff B, Naumann M (1999) INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB. Oncogene 18(16):2663-2666. doi:10.1038/sj.onc.1202617 (Pubitemid 29216690)
16. Perkins ND (2004) NF-[kappa]B: tumor promoter or suppressor? Trends Cell Biol 14(2):64-69
17. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70 (Pubitemid 30046295)
18. Nam EJ, Kim YT (2008) Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol Cancer 18(6):1169-1182. doi:10.1111/j.1525-1438. 2008.01191.x
19. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9(3):153-166. doi:10.1038/nrc2602
20. Bose S, Chandran S, Mirocha JM, Bose N (2006) The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol 19(2):238-245 (Pubitemid 43117608)
21. Cobrinik D (2005) Pocket proteins and cell cycle control. Oncogene 24(17):2796-2809. doi:10.1038/sj.onc.1208619
22. Than NG, Sumegi B, Bellyei S, Berki T, Szekeres G, Janaky T, Szigeti A, Bohn H, Than GN (2003) Lipid droplet and milk lipid globule membrane associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical carcinoma cells. Eur J Biochem 270(6):1176-1188 (Pubitemid 36384450)
23. Gasparian AV, Yao YJ, Lu J, Yemelyanov AY, Lyakh LA, Slaga TJ, Budunova IV (2002) Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells. Mol Cancer Ther 1(12):1079-1087
24. Ramdass B, Maliekal TT, Lakshmi S, Rehman M, Rema P, Nair P, Mukherjee G, Reddy BK, Krishna S, Radhakrishna Pillai M (2007) Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol Oncol 104(2):352-361 (Pubitemid 46135657)
25. Bali A, O'Brien PM, Edwards LM, Sutherland RL, Hacker NF, Henshall SM (2004) Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res 10(15):5168-5177. doi: 10.1158/1078-0432.CCR-03-0751 (Pubitemid 39099792)
26. Kusume T, Tsuda., kawabata M, Inoue T, Umesaki N, Suzuki T, Kumio Y (1999) The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer. Clin Cancer Res 5(12): 4152-4157